AVAMAB Concentrate for Solution for Infusion 400mg/16mL
Product details
Registration number: SIN17102P
Classification: Prescription Only
Active ingredients: Bevacizumab
Strength: 400mg/16ml
Dosage form: INFUSION, SOLUTION CONCENTRATE
Route: INTRAVENOUS
Registrant: INNOGENE KALBIOTECH PTE. LTD.
ATC code: L01FG01
HSA approval date: 25 September 2024
Manufacturer(s): UNIVERSAL FARMA, S.L.
Manufacturing country/countries: SPAIN
What are the HSA registration number and classification for AVAMAB Concentrate for Solution for Infusion 400mg/16mL?
According to the HSA dataset updated 7 August 2026:
Registration number: SIN17102P
Classification: Prescription Only
What active ingredients and strength are recorded for AVAMAB Concentrate for Solution for Infusion 400mg/16mL?
According to the HSA dataset updated 7 August 2026:
Active ingredients: Bevacizumab
Strength: 400mg/16ml
Ingredients and strengths are listed separately as recorded by HSA; their positions do not establish a one-to-one match. This is not a dosing instruction.
What dosage form and route are recorded for AVAMAB Concentrate for Solution for Infusion 400mg/16mL?
According to the HSA dataset updated 7 August 2026:
Dosage form: INFUSION, SOLUTION CONCENTRATE
Route: INTRAVENOUS
Who is the recorded registrant for AVAMAB Concentrate for Solution for Infusion 400mg/16mL?
According to the HSA dataset updated 7 August 2026:
Registrant: INNOGENE KALBIOTECH PTE. LTD.
Which manufacturers and countries are listed for AVAMAB Concentrate for Solution for Infusion 400mg/16mL?
According to the HSA dataset updated 7 August 2026:
Manufacturer(s): UNIVERSAL FARMA, S.L.
Manufacturing country/countries: SPAIN
Where can I look up AVAMAB Concentrate for Solution for Infusion 400mg/16mL in the HSA register?
Open HSA’s therapeutic product register and search for registration number SIN17102P or the exact product name AVAMAB Concentrate for Solution for Infusion 400mg/16mL. The general register link does not preselect this product.
What are the source dates for this AVAMAB Concentrate for Solution for Infusion 400mg/16mL record?
This record is from HSA’s List of Registered Therapeutic Products on data.gov.sg. Dataset update: 7 August 2026. Retrieval date: 13 November 2026.
The dataset date is a snapshot date, not a separate current-register check for every product. Later direct checks are recorded separately.
Has this AVAMAB Concentrate for Solution for Infusion 400mg/16mL record had a separate HSA register check?
No separate current-register check is recorded for this product. Its presence in the imported dataset does not establish its current registration status.
Search the HSA register using SIN17102P for the latest record.
Sources and dates
HSA dataset: 2026. Updated: 13 November 2026.
Factual product information only; no dosing, treatment or suitability advice.
Updated and reviewed by: Dr Joel Lim MBChB UK (PG Dip Dermatology), Resident Physician.
.png)